This topic contains a solution. Click here to go to the answer

Author Question: Pseudomutuality refers to: a. hostile exchanges between family members b. the appearance of an ... (Read 51 times)

schs14

  • Hero Member
  • *****
  • Posts: 569
Pseudomutuality refers to:
 
  a. hostile exchanges between family members
  b. the appearance of an open relationship without really having one
  c. the development of strong personal identities among family members
  d. none of the above

Question 2

One of Bowen's innovative research techniques was:
 
  a. to have families move in with their hospitalized schizophrenic member
  b. to study double-bind messages in schizophrenic's families
  c. to study double-bind messages in normal families
  d. all of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ong527

  • Sr. Member
  • ****
  • Posts: 285
Answer to Question 1

B

Answer to Question 2

A




schs14

  • Member
  • Posts: 569
Reply 2 on: Jun 19, 2018
YES! Correct, THANKS for helping me on my review


aliotak

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Excellent

 

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library